Bristol-Myers Squibb (BMY) has exhibited a long-term uptrend, with shares rising 18% over the past year and 9% year-to-date. However, the stock has entered a sideways consolidation phase after posting higher highs and lows. Over the last 30 days, BMY declined about 3%, reflecting a pullback from recent highs near 61. This horizontal bullish consolidation holds above prior lows, with traders noting a descending pennant formation that could signal continuation higher upon breakout.
Key support levels cluster around 57.50-58.00, including pivot S1 at 58.04 and a demand zone at 56.99-57.47. A break below could target deeper support near 45, though unlikely in the current structure. Resistance begins at 58.35-59.70, aligning with the 20-day MA at 58.66 and prior highs. Further upside faces hurdles at 60.41 and 61.09-62.38. Pivot point sits at 58.10, with price recently testing this zone after closing at 57.78.
BMY trades below its short- to medium-term moving averages, generating sell signals across the board. The 5-day MA is at 58.15, 20-day at 58.66, 50-day at 59.10, 100-day at 58.77, and 200-day at 58.92. This alignment below MAs confirms short-term bearish pressure, though the longer-term uptrend remains intact as price holds above broader 200-day levels in some analyses. A crossover above the 50-day MA would signal renewed bullish momentum.
The RSI(14) reading of approximately 30-48 points to neutral to oversold territory, with recent dips to 30.45 suggesting exhaustion in selling pressure. Stochastic(9,6) at 30.55 and Williams %R at -98.6 reinforce oversold conditions. MACD(12,26) stands at -0.3, with a sell signal as the histogram remains negative. ADX(14) above 40 indicates a strong downtrend component short-term, while CCI(14) at -187 signals oversold momentum. These readings collectively point to potential mean reversion if support holds.
Price action over the last quarter shows consolidation within a higher range compared to prior periods, with volume supporting key levels without significant spikes. Recent sessions featured bearish candles rejecting resistance near 59, but oversold oscillators and holding support suggest accumulation. Traders watch for volume confirmation on any breakout from the current pennant-like structure.
Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to scrutinize vast datasets including technical indicators, price patterns, and historical trends for BMY. These signals identify potential buy opportunities during uptrends or oversold bounces and sell signals amid breakdowns or overbought conditions. By recognizing recurring patterns like pennants or MA crossovers, the AI provides traders with objective entry/exit points, trend confirmations, and risk management aids. Widely used to complement manual chart analysis, these tools enhance decision-making in volatile markets. Explore the latest signals for BMY to inform your trading strategy.
Traders eye a potential rebound from current oversold levels if support at 57.50-58.00 holds, targeting resistance at 58.35-59.70 and a breakout above the 50-day MA. Conversely, a close below 57.50 could accelerate toward lower pivots. Monitor RSI for divergence, MACD histogram for bullish crossover, and volume for confirmation of direction. The bullish pennant setup remains valid above key demand zones, with focus on these levels for near-term price action.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
A.I.dvisor indicates that over the last year, BMY has been loosely correlated with PFE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if BMY jumps, then PFE could also see price increases.
| Ticker / NAME | Correlation To BMY | 1D Price Change % | ||
|---|---|---|---|---|
| BMY | 100% | +0.40% | ||
| PFE - BMY | 59% Loosely correlated | +0.15% | ||
| AMGN - BMY | 57% Loosely correlated | +0.32% | ||
| NVS - BMY | 55% Loosely correlated | -0.55% | ||
| GSK - BMY | 53% Loosely correlated | +0.34% | ||
| ABBV - BMY | 52% Loosely correlated | +1.32% | ||
More | ||||